Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), announced that the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from the Drug Regulatory Authority of Pakistan ("DRAP"), further supporting the Company’s commercial activities in the country.

The registrations build on Baird Medical’s existing presence in Pakistan, where the Company announced regulatory approvals and initial commercial availability at the Armed Forces Institute of Radiology & Imaging ("AFIRI") in January 2026. The latest registrations further expand the regulatory foundation supporting the availability and use of Baird Medical’s microwave ablation technology in the market.